Korro Bio, Inc. (KRRO)

NASDAQ: KRRO · IEX Real-Time Price · USD
89.53
+1.00 (1.12%)
Mar 28, 2024, 3:58 PM EDT - Market closed

Total Valuation

Korro Bio has a market cap or net worth of $374.13 million. The enterprise value is $237.63 million.

Market Cap 374.13M
Enterprise Value 237.63M

Important Dates

The next estimated earnings date is Tuesday, April 9, 2024, before market open.

Earnings Date Apr 9, 2024
Ex-Dividend Date n/a

Share Statistics

Korro Bio has 8.02 million shares outstanding. The number of shares has increased by 499.32% in one year.

Shares Outstanding 8.02M
Shares Change (YoY) +499.32%
Shares Change (QoQ) +107.10%
Owned by Insiders (%) 7.66%
Owned by Institutions (%) 72.04%
Float 2.26M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.20
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.87, with a Debt / Equity ratio of 0.20.

Current Ratio 8.87
Quick Ratio n/a
Debt / Equity 0.20
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -106.30% and return on invested capital (ROIC) is -41.62%.

Return on Equity (ROE) -106.30%
Return on Assets (ROA) -72.30%
Return on Capital (ROIC) -41.62%
Revenue Per Employee n/a
Profits Per Employee -$854,442
Employee Count 95
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Korro Bio has paid $27,000 in taxes.

Income Tax 27,000
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average 55.99
200-Day Moving Average n/a
Relative Strength Index (RSI) 79.87
Average Volume (30 Days) 24,155

Short Selling Information

The latest short interest is 129,610, so 1.62% of the outstanding shares have been sold short.

Short Interest 129,610
Short Previous Month 123,995
Short % of Shares Out 1.62%
Short % of Float 5.73%
Short Ratio (days to cover) 1.82

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -84.53M
Pretax Income -81.15M
Net Income -81.17M
EBITDA -73.91M
EBIT -81.15M
Earnings Per Share (EPS) -$53.08
Full Income Statement

Balance Sheet

The company has $169.71 million in cash and $33.21 million in debt, giving a net cash position of $136.51 million or $17.02 per share.

Cash & Cash Equivalents 169.71M
Total Debt 33.21M
Net Cash 136.51M
Net Cash Per Share $17.02
Equity / Book Value 169.91M
Book Value Per Share 21.18
Working Capital 153.25M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$67.28 million and capital expenditures -$7.84 million, giving a free cash flow of -$75.12 million.

Operating Cash Flow -67.28M
Capital Expenditures -7.84M
Free Cash Flow -75.12M
FCF Per Share -$49.12
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Korro Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -499.32%
Shareholder Yield -499.32%
Earnings Yield -21.70%
FCF Yield -20.08%

Analyst Forecast

The average price target for Korro Bio is $126.25, which is 41.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target $126.25
Price Target Difference 41.02%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on November 6, 2023. It was a reverse split with a ratio of 1:50.

Last Split Date Nov 6, 2023
Split Type Reverse
Split Ratio 1:50

Scores

Altman Z-Score n/a
Piotroski F-Score 2